Literature DB >> 19477100

Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona. The rapporteurs' report.

Stefan J Borgwardt1, Chandlee Dickey, Hilleke Hulshoff Pol, Thomas J Whitford, Lynn E DeLisi.   

Abstract

In 1990 a satellite session of the American College of Neuropsychopharmacology (ACNP) Annual Meeting was held that focused on the question of whether progressive changes in brain structure occur in schizophrenia and this session raised considerable controversy. Eighteen years later, on December 12, 2008, after much data have since accumulated on this topic, a group of approximately 45 researchers gathered after the annual ACNP meeting to participate in a similar workshop on several unresolved questions still remaining: (1) How strong and consistent is the evidence? (2) Is there anatomic specificity to changes and is it disease specific or subject specific? (3) What is the time course? (4) What is the underlying pathophysiology (i.e. is it central to the disease process or is it due to neuroleptic treatment or other epiphenomena? (5) What is its clinical significance? and (6) Are there treatment implications? The day was chaired by Lynn E. DeLisi and co-chaired by Stephen J. Wood. Christos Pantelis and Jeffrey A. Lieberman extensively helped with its planning. The ACNP assisted in its organization as an official satellite of its annual meeting and several pharmaceutical companies provided support with unrestricted educational grants. The following is a summary of the sessions as recounted by rapporteurs whose job was to record as closely as possible the outcome of discussions on the above outlined questions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477100     DOI: 10.1016/j.schres.2009.04.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  9 in total

1.  Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia.

Authors:  Jong H Yoon; Danh V Nguyen; Lindsey M McVay; Paul Deramo; Michael J Minzenberg; J Daniel Ragland; Tara Niendham; Marjorie Solomon; Cameron S Carter
Journal:  Schizophr Res       Date:  2012-01-25       Impact factor: 4.939

2.  Progress in Schizophrenia Research and Treatment.

Authors: 
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

3.  What a Clinician Should Know About the Neurobiology of Schizophrenia: A Historical Perspective to Current Understanding.

Authors:  Lynn E DeLisi
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

4.  Aging effects on regional brain structural changes in schizophrenia.

Authors:  Igor Nenadić; Heinrich Sauer; Stefan Smesny; Christian Gaser
Journal:  Schizophr Bull       Date:  2011-02-04       Impact factor: 9.306

5.  Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study.

Authors:  Natalya A Uranova; Olga V Vikhreva; Valentina I Rachmanova; Diana D Orlovskaya
Journal:  Schizophr Res Treatment       Date:  2011-06-28

6.  Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.

Authors:  Ulysses S Torres; Fabio L S Duran; Maristela S Schaufelberger; José A S Crippa; Mario R Louzã; Paulo C Sallet; Caroline Y O Kanegusuku; Helio Elkis; Wagner F Gattaz; Débora P Bassitt; Antonio W Zuardi; Jaime Eduardo C Hallak; Claudia C Leite; Claudio C Castro; Antonio Carlos Santos; Robin M Murray; Geraldo F Busatto
Journal:  Neuroimage Clin       Date:  2016-06-03       Impact factor: 4.881

7.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

Review 8.  Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review.

Authors:  B H Ebdrup; H Nørbak; S Borgwardt; B Glenthøj
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 9.  Dysfunction in the coagulation system and schizophrenia.

Authors:  S Hoirisch-Clapauch; O B Amaral; M A U Mezzasalma; R Panizzutti; A E Nardi
Journal:  Transl Psychiatry       Date:  2016-01-05       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.